Cytotoxic Effect of Tumour Necrosis Factor-Alpha on Sarcoma F Cells at Tumour Relevant Oxygen Tensions

References

• Carswell E A, Old L J, Kassel R L, Green S, Fiore N, Williamson B. An endotoxin-induced serum factor that causes necrosis of tumours. Proc Natl Acad Sci USA 1975; 72: 3666–70
   PubMed Web of Science ®Google Scholar
• Meager A, Leung H, Wooley J. Assays for tumour necrosis factor and related cytokines. J. Immunol Methods 1988; 116: 1–17
   Google Scholar
• Lartigau E, Le Ridant A M, Lambin P, et al. Oxygenation of head and neck tumors. Cancer 1993; 71: 2319–25
   PubMed Web of Science ®Google Scholar
• Vaupel P, Schlenger K, Knoop C, Hoeckel M. Oxygenation of human tumours: Evaluation of tissue oxygen distribution in breast cancers by computerised O2 tension measurements. Cancer Res 1991; 51: 3316–22
   PubMed Web of Science ®Google Scholar
• Sampson L E, Chaplin D J. The influence of microenvironment on the cytotoxicity of TNFα in vitro. Int J Radiat Oncol Biol Phys 1994; 29: 467–71
   PubMedGoogle Scholar
• Park Y MK, Anderson R L, Spitz D R, Hahn G M. Hypoxia and resistance to hydrogen peroxide confer resistance to tumour necrosis factor in murine L929 cells. Radiat Res 1992; 131: 162–8
   PubMed Web of Science ®Google Scholar
• Matthews N, Neale M L, Jackson S K, Stark J M. Tumour cell killing by tumour necrosis factor: inhibition by anaerobic conditions, free radical scavengers and inhibitors of arachidonate metabolism. Immunology 1987; 62: 153–5
   PubMed Web of Science ®Google Scholar
• Loeffler D A, Juneau P L, Masserant S. Influence of tumour physio-chemical conditions in interleukin-2-stimulated lymphocyte proliferation. Br J Cancer 1992; 66: 619–22
   PubMedGoogle Scholar
• Aune T M, Pogue S. Inhibition of tumour cell growth by Interferon-γ is mediated by two distinct mechanisms, dependent on tumour oxygenation, induction of tryptophan degradation and depletion of intracellular nicotinamide adenine dinucleotide. J Clin Invest 1989; 84: 863–75
   PubMed Web of Science ®Google Scholar
• Wing D A, Talley G D, Storch T G. Oxygen concentration regulates EGF-induced proliferation and EGF-receptor down regulation. Biochem Biophys Res Commun 1988; 153: 952–8
   PubMedGoogle Scholar
• Naldini A, Cesari S, Bocci V. Effects of hypoxia on the cytotoxicity mediated by tumour necrosis factor α. Lymphokine and Cytokine Res 1994; 13: 233–7
   PubMedGoogle Scholar
• Tartaglia L A, Rothe M, Hu Y-F, Goeddel D V. Tumour necrosis factor's cytotoxic activity is signaled by the p55 TNF receptor. Cell 1993; 73: 213–6
   PubMed Web of Science ®Google Scholar
• Zimmerman R J, Chan A, Leadon S A. Oxidative damage in murine tumour cells treated in vitro by recombinant human tumour necrosis factor. Cancer Res 1989; 49: 1644–8
   PubMed Web of Science ®Google Scholar
• Yamauchi N, Kuriyama H, Watanabe N, Neda H, Maeda M, Niitsu Y. Intracellular hydroxyl radical production induced by recombinant tumour necrosis factor and its implication in the killing of tumour cells in vitro. Cancer Res 1989; 49: 1671–5
   PubMed Web of Science ®Google Scholar
• Wong C HW, Elwell J H, Oberley L W, Geoddel D V. Manganous superoxide dismutase is essential for cellular resistance to cytotoxicity of tumour necrosis factor. Cell 1989; 58: 923–31
   PubMed Web of Science ®Google Scholar
• Zyad A, Benard J, Tursz T, Clarke R, Chouaib S. Resistance to TNFα and Adriamycin in the human breast cancer MCF-7 cell line: relationship to MDR1, MnSOD and TNF gene expression. Cancer Res 1994; 54: 825–31
   PubMed Web of Science ®Google Scholar
• Vanhaesebroeck B, Decoster E, Van Ostade X, et al. Expression of an exogenous tumour necrosis factor (TNF) gene in TNF sensitive cell lines confers resistance to TNF mediated cell lysis. J Immunol 1992; 148: 2785–94
   PubMedGoogle Scholar
• Himeno T, Watanabe N, Yamauchi N, et al. Expression of endogenous TNF as a protective protein against the cytotoxicity of exogenous TNF. Cancer Res 1990; 50: 4941–5
   PubMed Web of Science ®Google Scholar
• Scannel G, Waxman K, Kaeml G J, et al. Hypoxia induces a human macrophage cell line to release tumour necrosis factor α and its soluble receptors in vitro. J. Surg Res 1993; 54: 281–5
   PubMedGoogle Scholar
• Belizario J E, Dinarello C A. Interleukin 1, interleukin 6, tumour necrosis factor and transforming growth factor-β increase cell resistance to tumour necrosis factor cytotoxicity by growth arrest in the G1 phase of the cell cycle. Cancer Res 1991; 51: 2379–85
   PubMed Web of Science ®Google Scholar
• Watanabe N, Niitsu Y, Yamauchi N, et al. Cell cycle specificity of tumour necrosis factor and its receptor. Cell Biol Int Reports 1987; 11: 813–7
   PubMedGoogle Scholar
• Coffman F D, Haviland D L, Green L M, Ware C F. Cytotoxicity by tumor necrosis factor is linked with the cell cycle but does not require DNA synthesis. Growth factors 1989; 1: 357–64
   PubMedGoogle Scholar
• Darzynkiewicz Z, Williamson B, Carswell E A, Old L J. Cell cycle specific effects of tumor necrosis factor. Cancer Res 1984; 44: 83–90
   PubMed Web of Science ®Google Scholar